Overall Score

Growth

Revenue base is still modest relative to valuation, with price-to-sales at 3.04 and EV/sales at 8.30.

Profitability is positive but not yet strong enough to support a high-growth thesis, with net margin at 16.6% and ROIC at 1.4%.

Financial Health

Liquidity is strong, with a current ratio of 5.83 and cash ratio of 4.98.

Balance-sheet leverage remains elevated, with debt-to-equity at 1.56 and net debt to EBITDA at 11.35.

Cash generation is weak, with operating cash flow and free cash flow both negative over the trailing twelve months.

Profitability

Gross margin is healthy at 56.6% and operating margin is strong at 46.3%.

Returns on capital remain low, with ROE at 4.2% and ROIC at 1.4%.

Valuation

The stock screens as inexpensive on book value, with price-to-book at 0.81 and price-to-fair-value at 0.81.

However, valuation is harder to justify on cash flow because free cash flow is negative and EV/FCF is not meaningful.

Momentum

No recent news was provided to indicate a change in business momentum.

The current setup remains mixed, with solid margins offset by weak cash flow and leverage.